This post is part of a symposium on Amy Kapczynski’s essay “The Right to Medicines in an Age of Neoliberalism.” All contributions to the symposium can be found here. Introduction Amy Kapczynski’s article presciently points out the weaknesses of the judicialization of the right to medicines, and its failure “to engage a foundational aspect of [these cases]: the political economy of medicines that they assume.”[1] Kapczynski argues that these cases suggest that a right to medicines “imbricated” within the prevailing neoliberal regime is plausibly regressive: Continue reading →